Novel scaffolds for modulation of NOD2 identified by pharmacophore-based virtual screeningGuzelj, Samo (Avtor) Tomašič, Tihomir (Avtor) Jakopin, Žiga (Avtor) antagonisthomology modelingNOD2Nucleotide-binding oligomerizationpharmacophore modelingvirtual screeningNucleotide-binding oligomerization domain-containing protein 2 (NOD2) is an innate immune pattern recognition receptor responsible for the recognition of bacterial peptidoglycan fragments. Given its central role in the formation of innate and adaptive immune responses, NOD2 represents a valuable target for modulation with agonists and antagonists. A major challenge in the discovery of novel small-molecule NOD2 modulators is the lack of a co-crystallized complex with a ligand, which has limited previous progress to ligand-based design approaches and high-throughput screening campaigns. To that end, a hybrid docking and pharmacophore modeling approach was used to identify key interactions between NOD2 ligands and residues in the putative ligand-binding site. Following docking of previously reported NOD2 ligands to a homology model of human NOD2, a structure-based pharmacophore model was created and used to virtually screen a library of commercially available compounds. Two compounds, 1 and 3, identified as hits by the pharmacophore model, exhibited NOD2 antagonist activity and are the first small-molecule NOD2 modulators identified by virtual screening to date. The newly identified NOD2 antagonist scaffolds represent valuable starting points for further optimization.20222022-08-09 11:41:03Neznano138680UDK: 615.4:54:616-006ISSN pri članku: 2218-273XDOI: 10.3390/biom12081054COBISS_ID: 117616387sl